The Predictive Value of Complement C3 in Patients With Advanced Gastric Cancer
Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
This study is designed to investigate whether complement C3 depletion is associated with poor
short-term outcomes in postoperative patients with gastric cancer.
Details
Lead Sponsor:
First Affiliated Hospital, Sun Yat-Sen University
Treatments:
Complement C3 Complement System Proteins Oxaliplatin